Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Human medicines European public assessment report (EPAR): Yellox, bromfenac, Date of authorisation: 18/05/2011, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 5, Status: Authorised
PSUSA/00000026/202405
Agenda of the CAT meeting 22-24 January 2025
European Medicines Agency Write PMS API implementation Guide (zip)
European Medicines Agency Write PMS API implementation Guide
Agenda of the COMP meeting 21-23 January 2025
Agenda - Medicine Shortages (SPOC) Working Party 21 January 2025
PDCO work plan 2025